VST and OKLO shares have been massive winners in the early innings of the AI boom.

FFIV surges nearly 8% after Q3 earnings and revenues beat estimates, driven by strong product growth and a raised 2025 outlook.

TYL's Q2 results reflect the benefits of a rise in subscription revenues, primarily driven by new software contracts.

HOOD's Q2 earnings crush estimates as surging trading activity and higher net interest revenues fuel strong growth.

Higher operating expenses and a decline in oil production hurt AR's Q2 earnings.

STLA is deeply undervalued, trading at a 68% discount to book and under 4x earnings, despite strong brands and a solid balance sheet. Recent results were rough, but sequential trends are improving with new product launches and recovering volumes, signaling a turnaround is underway. Tariffs are a real headwind, but their impact is overstated; STLA is better positioned than peers and actively adapting its operations.

Baxter International cut its 2025 profit forecast on Thursday, while quarterly earnings missed analysts' estimates due to the lingering effect of Hurricane Helene, which damaged a key manufacturing facility and reduced demand for IV solutions.

Key Points in This Article: Meta Platforms‘ (META) Q2 revenue reached $47.5 billion, with ad revenue up 21% to $46.5 billion, driving a 36% net income increase to $18.3 billion.

Tech stocks surge premarket as Microsoft and Meta beat earnings forecasts. S&P 500 and Nasdaq 100 futures rally despite Fed inflation concerns today.

SMH hit a fresh 52-week high, surging nearly 75% from its low as AI-fueled chip demand powers semiconductor stocks.

NBR expects capital expenditures for the third quarter of 2025 to be between $200 million and $210 million.

WMB is expected to have earned higher revenues in the second quarter. However, increased costs are anticipated to have impacted its bottom line.

Huntington Ingalls (HII) came out with quarterly earnings of $3.86 per share, beating the Zacks Consensus Estimate of $3.23 per share. This compares to earnings of $4.38 per share a year ago.

Eli Lilly and Co. LLY released topline results from SURPASS-CVOT, a head-to-head Phase 3 cardiovascular outcomes trial comparing Mounjaro (tirzepatide), a GIP/GLP-1 dual receptor agonist, to Trulicity (dulaglutide), a GLP-1 receptor agonist.

DALLAS , July 31, 2025 /PRNewswire/ -- AT&T (NYSE:T) announced today the dual listing of its common stock on NYSE Texas, the newly launched fully electronic equities exchange headquartered in Dallas, Texas, effective Aug. 1, 2025. "AT&T has a longstanding relationship with the New York Stock Exchange, which has been integral to our continued financial growth and success," said John Stankey, AT&T Chairman and CEO.

July 31, 2025 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) ADR Ratio Change Effective ADSs Outstanding Post Ratio Change Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs, today announces the previously announced ratio change of its American Depositary Receipts (“ADR”) from one (1) ADR representing ten thousand (10,000) ordinary shares, to the new ratio of one (1) ADR representing one hundred thousand (100,000) ordinary shares (the "Ratio Change"), became effective at the open of business on July 31, 2025 (U.S. Eastern Time). For …

Banzai International, Inc. is a software-as-a-service (SaaS) marketing technology (MarTech) company that provi and AI-driven marketing and sales solutions.

SALT LAKE CITY , July 31, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its second quarter 2025 financial results on Thursday, August 14, 2025, after the market close. The Company will also host a conference call and webcast on the same day at 4:30 p.m.

Regina, Saskatchewan--(Newsfile Corp. - July 31, 2025) - Above Food Ingredients Inc. (NASDAQ: ABVE) ("Above Food" or the "Company") today issued an update regarding its proposed merger with Palm Global Technologies Limited ("Palm Global"), including a shareholder letter from Palm Global Chairman, Peter Knez. The letter confirms that nearly 90% of Palm Global shareholders have already committed their support for the transaction.

As of July 31, 2025, two stocks in the consumer staples sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.